[go: up one dir, main page]

WO2004005292A1 - Novel antibiotics against vibrio anguillarum and the applications thereof in cultures of fish, crustaceans, molluscs and other aquaculture activities - Google Patents

Novel antibiotics against vibrio anguillarum and the applications thereof in cultures of fish, crustaceans, molluscs and other aquaculture activities Download PDF

Info

Publication number
WO2004005292A1
WO2004005292A1 PCT/ES2003/000325 ES0300325W WO2004005292A1 WO 2004005292 A1 WO2004005292 A1 WO 2004005292A1 ES 0300325 W ES0300325 W ES 0300325W WO 2004005292 A1 WO2004005292 A1 WO 2004005292A1
Authority
WO
WIPO (PCT)
Prior art keywords
proline
antibiotics
cycle
cultures
aquaculture
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Ceased
Application number
PCT/ES2003/000325
Other languages
Spanish (es)
French (fr)
Inventor
Ricardo Riguera Vega
José Luis SÁNCHEZ LÓPEZ
Faouzi Ben Mohamed Fdhila
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Universidade de Santiago de Compostela
Original Assignee
Universidade de Santiago de Compostela
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Universidade de Santiago de Compostela filed Critical Universidade de Santiago de Compostela
Publication of WO2004005292A1 publication Critical patent/WO2004005292A1/en
Anticipated expiration legal-status Critical
Ceased legal-status Critical Current

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D487/00Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00
    • C07D487/02Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00 in which the condensed system contains two hetero rings
    • C07D487/04Ortho-condensed systems
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00Medicinal preparations containing peptides
    • A61K38/04Peptides having up to 20 amino acids in a fully defined sequence; Derivatives thereof
    • A61K38/12Cyclic peptides, e.g. bacitracins; Polymyxins; Gramicidins S, C; Tyrocidins A, B or C
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04Antibacterial agents
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12NMICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N1/00Microorganisms, e.g. protozoa; Compositions thereof; Processes of propagating, maintaining or preserving microorganisms or compositions thereof; Processes of preparing or isolating a composition containing a microorganism; Culture media therefor
    • C12N1/20Bacteria; Culture media therefor
    • C12N1/205Bacterial isolates
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12PFERMENTATION OR ENZYME-USING PROCESSES TO SYNTHESISE A DESIRED CHEMICAL COMPOUND OR COMPOSITION OR TO SEPARATE OPTICAL ISOMERS FROM A RACEMIC MIXTURE
    • C12P17/00Preparation of heterocyclic carbon compounds with only O, N, S, Se or Te as ring hetero atoms
    • C12P17/18Preparation of heterocyclic carbon compounds with only O, N, S, Se or Te as ring hetero atoms containing at least two hetero rings condensed among themselves or condensed with a common carbocyclic ring system, e.g. rifamycin
    • C12P17/182Heterocyclic compounds containing nitrogen atoms as the only ring heteroatoms in the condensed system
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12RINDEXING SCHEME ASSOCIATED WITH SUBCLASSES C12C - C12Q, RELATING TO MICROORGANISMS
    • C12R2001/00Microorganisms ; Processes using microorganisms
    • C12R2001/01Bacteria or Actinomycetales ; using bacteria or Actinomycetales

Definitions

  • Vibriosis is one of the diseases that causes the most economic losses in marine aquaculture (Toranzo and Barja. 1990; Myhr et al. 1991). This disease is caused by different bacterial species belonging to the genus Vibrio, being the species Vibrio anguillarum the main responsible for epizootics in a wide variety of fish, crustaceans and mollusks. In Galicia (NW of Spain), vibriosis has been a continuous and limiting problem in marine fish farming over the years. Since 1985 Vibrio anguillarum has been the main causative agent of vibriosis in turbot fry, being sporadically isolated from salmon and rainbow trout (Toranzo et al.
  • the main chemotherapeutic agents so far used in marine aquaculture are oxytetracycline, classical quinolones (oxolinic acid, flumechin) and fluorinated (enrofloxacin), and nitrofurans.
  • Oxolinic acid and flumequine have become obsolete due to the emergence of resistant strains, while enrofloxacin and florfenicol are being used despite not being approved for use in fish due to the possible occurrence of resistant strains while no new chemotherapeutic agents are found. effective.
  • the use of nitrofurans has been banned in aquaculture.
  • 155 bacterial strains ⁇ were introduced from the larval culture water of Pectén maximus ⁇ which were introduced into Petri dishes with a basal agar-marine medium (5 g / L bacteriological peptone, yeast extract: 1 g / L, ferric citrate strokes and Bacteriological agar: 14 g / L) pH 7.6 characterized by its saline content, and incubated at a temperature of 23 ° C in both liquid and plate cultures.
  • a basal agar-marine medium 5 g / L bacteriological peptone, yeast extract: 1 g / L, ferric citrate strokes and Bacteriological agar: 14 g / L
  • pH 7.6 characterized by its saline content
  • sterile filter paper discs with a diameter of 5 mm, were impregnated with the supernatant, and were deposited on agar plates previously seeded in striations with the Vibrio anguillarum and subsequently incubated for 24-48 h at 23 ° C. The activity was determined by the inhibition halo.
  • Microplate assays in the marine broth were carried out with pure cultures of the different bacterial and coculture strains of the chosen bacterial strain, plus the control strain. To each well of a 96-well microplate, 200 ⁇ l of marine broth and 10 ⁇ l of supernatants from different strains were added. Finally, they were added to each well
  • a colony of bacterial strains CF-20 or C-148 and another of V. anguillarum were seeded and grown in marine agar, inoculated in coculture in flasks of 1.8 L capacity with 1200 mL of marine broth each and were incubated at 23 ° C with orbital shaking at 140 rpm for 24 h.
  • the active fractions obtained from the column were chromatographed by HPLC on a normal phase serrüpreparative column ( ⁇ -porasil; hexane: AcOEt 2: 3; flow: 3 mL / min) providing 3.5 mg of Z54 with a t R of 22 min; 4 mg of Z56 with a t R of 29 min; 3 mg Z57 with a t R of 37 and 5 mg of Z59 with a t R of 44 min.
  • 45 L of culture supernatant of strain C-148 were extracted and chromatographed as before.
  • the active fractions eluted from the chromatography column provided an impure compound that was purified by HPLC on a reverse phase column ( ⁇ -Bondapak C-18; MeOH: H 2 O 95: 5; flow: 2 mL / min) giving 3 mg of pure active B717 with a t R of 17 min and a mixture that subjected to HPLC in a semi-preparative column of normal phase ( ⁇ -porasil; hexane-AcOEt 2: 3; flow: 3 mL / min) provided important active compounds against to Vibrio anguillarum 4 mg of Z54; 3.5 mg of Z56; 3 mg of Z57 and 2.5 mg of Z59. All compounds showed optical activity (Table 1) and were identified as diketopiperacins.
  • Table 1 Retention times t (min), ⁇ D and fragments in antibiotic mass spectrometry.
  • Protected dipeptides such as BOC (butyloxycarbonyl) and methyl ester were first prepared and cycled by heating in formic acid / BuOH / Toluene.
  • BOC butyloxycarbonyl
  • the LL and DD diketopiperacins of Table 2 were prepared, except for B717 which was obtained by coupling between Cbz- (D) -trans-4-hydroxy- (D) -proline with (D) -phenylalanine methyl ester followed of N-deprotection by catalytic hydrogenation and cyclization to give compound B717.
  • diketopiperacin DD or LL are dissolved in 0.3 rnL of sodium hydroxide (0.5 mL of 0.5 N NaOH in H 2 O: MeOH, 1: 1) and kept for 15 min at room temperature. A few drops of 15% hydrochloric acid are added and left overnight. The solution is concentrated in vacuo and the residue is extracted with methylene chloride, the solvent is concentrated and crystallized with ethyl acetate.
  • MIC Minimum inhibitory concentration
  • the minimum inhibitory concentration (Civil) of the isolated active substances Z54, Z56, Z57, Z59 and B717 was determined by the agar dilution method described in the NCCLS guide (1997), with slight modifications in the composition of the medium, time of incubation and temperature. Solutions of the active substances were prepared at different concentrations (0.005; 0.05; 0.1; 0.2; 0.3; 0.4; 0.5; 0.7; 0.8 and 5 ⁇ g / mL) , and suspensions of V. anguillarum at different dilutions (from 10 to 10 cells / mL). Different concentrations of the active substances on Petri dishes previously seeded with V. anguillarum are then added and the inhibition halos measured after 24-48 hours. .
  • the larval cultures of Ruditapes decussatus and Ostrea edulis were kept in the laboratory at a controlled temperature of 20 ° C, the water being renewed and the bacterial flora in general and the V. anguillarum analyzed every two days.
  • Two types of Experiments The first in 100 mL tubes to make an approximate determination of the dose of each of the active substances that provides the best growth and / or survival of the larvae in relation to the control, and the second in 70 L tanks for confirm the most appropriate activity and dose, and approach the operating conditions in aquaculture.
  • the larvae from the previous experiments were collected in sieves, and suspended in a small volume of seawater, from which three 100 ⁇ L aliquots were taken and examined for the estimation of the average number of larvae and the calculation of survival.
  • samples of 1 mL of culture were taken that were diluted with sterile seawater to a dilution of 10 " .
  • Z54 is cycle (D) -proline- (D) -Isoleucma
  • Z56 is cycle (D) -proline- (D) -Leucine
  • Z57 is cycle (D) - proline- (D) -valine
  • Z59 is cycle (D) -proline- (D) -phenylalanine
  • B717 is cyclo (D) -trans-4-droxypropyl- (D) -phenylalarine.
  • Tables 1, 3 and 4 show the proton, carbon and E. mass NMR data of antibiotics isolated from bacterial strains.
  • Antibiotic activity of natural and synthetic diketopiperacins The synthesis of diketopiperacins with diverse stereochemistry, from alpha amino acids, allowed us to have a wide collection of compounds that were subjected to tests of their antibiotic activity together with natural samples (Table 2).
  • Table 2 Mimic ima inhibitory concentration (MIC; ⁇ g.mL "1 ) against V. anguillarum of a selection of diketopiperacins with stereochemistry DD, LD and DL.
  • Figure 3 shows the results of in vivo tests with larvae of Ruditapes decussatus mollusc, of the natural diketopiperacins isolated from strains CF-20 and C-148. In these experiments, it is observed that the survival of the larvae increases in values ranging from 12 to 33%, the most active compound being Z59 and the least active B717, there being no essential differences in the activity of the others that remain around 20%.
  • the high mortality in the control tanks clearly shows that the bacterial flora is the main cause of mortality of the larvae, as indicated by the values obtained for CFU and the observed changes in bacterial flora in general and in Vibrio.
  • a solution containing the antibiotic or mixture of the described natural and synthetic antibiotics is added to the tank at the beginning of the larval culture so that the final concentration is 0.5-1 ⁇ g / mL. After two days the water in the tank is renewed and the antibiotic solution is replenished, restoring the initial concentration. The process of water renewal and the addition of antibiotics is repeated up to a total of five times. After that time, (10 days) the treatment is terminated. Fish and crustacean treatment:

Landscapes

  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Organic Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Zoology (AREA)
  • Wood Science & Technology (AREA)
  • General Health & Medical Sciences (AREA)
  • Biotechnology (AREA)
  • Medicinal Chemistry (AREA)
  • Genetics & Genomics (AREA)
  • General Engineering & Computer Science (AREA)
  • Animal Behavior & Ethology (AREA)
  • Veterinary Medicine (AREA)
  • Pharmacology & Pharmacy (AREA)
  • General Chemical & Material Sciences (AREA)
  • Microbiology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Public Health (AREA)
  • Biochemistry (AREA)
  • Biomedical Technology (AREA)
  • Oncology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Communicable Diseases (AREA)
  • Immunology (AREA)
  • Tropical Medicine & Parasitology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Virology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Epidemiology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Peptides Or Proteins (AREA)

Abstract

The invention relates to novel antibiotics against Vibrio anguillarum and the applications thereof in cultures of fish, crustaceans, molluscs and other aquaculture activities. Five diketopiperazines with activity against Vibrio anguillarum have been discovered, namely compounds: cyclo(D)-proline-(D)-phenylalanine (Z59), cyclo(D)-proline-(D)-isoleucine (Z56), cyclo(D)-proline-(D)-valine (Z57), cyclo(D)-proline(D)-leucine (Z54) and cyclo(D)-hydroxyproline-(D)-phenylalanine (B717), which are obtained from two marine bacteria, Roseobacter gallaeciensis (CECT 5719) and Roseobacter sp. (CECT 5718), which are isolated from larval cultures of Pecten maximus. The addition of said compounds at a concentration of 0.5 mg/mL to cultures of fish, crustaceans and molluscs increases the survival capacity thereof with values varying between 12 % and 33 %. The inhibiting activity thereof is comparable to that of antibiotics used at present in aquaculture.

Description

TÍTULO TITLE

Nuevos antibióticos activos frente al Vibrio anguillarum y sus aplicaciones en cultivos de peces, crustáceos, moluscos y otras actividades de acuicultura.New active antibiotics against Vibrio anguillarum and its applications in fish, crustaceans, molluscs and other aquaculture activities.

DESCRIPCIÓN La vibríosis es una de las enfermedades que más pérdidas económicas causa en la acuicultura marina (Toranzo y Barja. 1990; Myhr et al. 1991). Esta enfermedad está causada por distintas especies bacterianas pertenecientes al género Vibrio, siendo la especie Vibrio anguillarum la responsable principal de epizootias en una gran variedad de peces, crustáceos y moluscos. En Galicia (NW de España), la vibriosis ha sido a través de los años un problema continuo y limitante en la piscicultura marina. Desde 1985 el Vibrio anguillarum ha sido el principal agente causal de vibriosis en alevines de rodaballo, siendo aislado esporádicamente a partir de salmón y de trucha arcoiris (Toranzo et al. 1987b; Toranzo y Baija. 1990). Del mismo modo, este Vibrio ha sido el causante de mortalidades en cultivos de peces marinos, moluscos y crustáceos de otras zonas geográficas (Masumura et al. 1989; Baticados et al.DESCRIPTION Vibriosis is one of the diseases that causes the most economic losses in marine aquaculture (Toranzo and Barja. 1990; Myhr et al. 1991). This disease is caused by different bacterial species belonging to the genus Vibrio, being the species Vibrio anguillarum the main responsible for epizootics in a wide variety of fish, crustaceans and mollusks. In Galicia (NW of Spain), vibriosis has been a continuous and limiting problem in marine fish farming over the years. Since 1985 Vibrio anguillarum has been the main causative agent of vibriosis in turbot fry, being sporadically isolated from salmon and rainbow trout (Toranzo et al. 1987b; Toranzo and Baija. 1990). In the same way, this Vibrio has been the cause of mortalities in marine fish, molluscs and crustaceans from other geographical areas (Masumura et al. 1989; Baticados et al.

1990; Lavilla-Pitogo et al. 1990; Paillard y Maes. 1990; Myhr et al. 1991; Castro et al. 1992).1990; Lavilla-Pitogo et al. 1990; Paillard and Maes. 1990; Myhr et al. 1991; Castro et al. 1992).

A la vista de los problemas descritos anteriormente, que reducen la productividad en las instalaciones de acuicultura, se ha recurrido de modo sistemático a la adición de antibióticos al medio de cultivo. Los principales agentes quimioterápicos hasta ahora usados en acuicultura marina son la oxitetraciclina, quinolonas clásicas (ácido oxolínico, flumequina) y fluoradas (enrofloxacina), y nitrofuranos. El ácido oxolínico y la flumequina han quedado obsoletos por la aparición de cepas resistentes, mientras que la enrofloxacina y el florfenicol se están usando a pesar de no estar aprobado su uso en peces ante la posible aparición de cepas resistentes mientras no se encuentran nuevos agentes quimioterápicos eficaces. Por su parte, el uso de los nitrofuranos ha sido prohibido en la acuicultura. En el caso concreto de los cultivos larvarios de vieira {Pectén máximas) y de otros bivalvos susceptibles de acuicultura, se ha comprobado que la utilización de agua de mar filtrada e irradiada con luz ultravioleta, y los cambios frecuentes del agua durante el cultivo, no son medidas suficientemente eficaces, siendo necesaria la utilización de antibióticos para prevenir las mortalidades bacterianas que generalmente aparecen de forma espontánea al cabo de una semana o dos de cultivo (Alderman y Michel. 1992; Nicolás et al. 1995).In view of the problems described above, which reduce productivity in aquaculture facilities, the addition of antibiotics to the culture medium has been systematically used. The main chemotherapeutic agents so far used in marine aquaculture are oxytetracycline, classical quinolones (oxolinic acid, flumechin) and fluorinated (enrofloxacin), and nitrofurans. Oxolinic acid and flumequine have become obsolete due to the emergence of resistant strains, while enrofloxacin and florfenicol are being used despite not being approved for use in fish due to the possible occurrence of resistant strains while no new chemotherapeutic agents are found. effective. For its part, the use of nitrofurans has been banned in aquaculture. In the specific case of scallop larval crops (pectén maxima) and other bivalves susceptible to aquaculture, it has been proven that the use of filtered and irradiated seawater with ultraviolet light, and frequent changes of water during cultivation, do not they are sufficiently effective measures, being necessary the use of antibiotics to prevent bacterial mortalities that usually appear spontaneously after a week or two of culture (Alderman and Michel. 1992; Nicolás et al. 1995).

Por todo ello, la búsqueda de nuevos antibióticos activos en el medio marino, capaces de proteger los cultivos en instalaciones de acuicultura y no generadores de contaminación, constituyen un tema de gran importancia y para el que son necesarias nuevas soluciones (Douillet et al. 1993, 1994; Nogami et al. 1992). EXPLICACIÓN DETALLADA DE LA INVENCIÓN Cepas bacterianas:Therefore, the search for new active antibiotics in the marine environment, capable of protecting crops in aquaculture facilities and not generating pollution, is a matter of great importance and for which new solutions are necessary (Douillet et al. 1993 , 1994; Nogami et al. 1992). DETAILED EXPLANATION OF THE INVENTION Bacterial strains:

Se aislaron del agua de cultivo larvario de Pectén maximus 155 cepas bacterianas^ que fueron introducidas en placas de Petri con un medio basal agar-marino (peptona bacteriológica 5 g/L, extracto de levadura: 1 g/L, trazos de citrato férrico y agar bacteriológico: 14 g/L) de pH 7,6 caracterizado por su contenido salino, e incubadas a una temperatura de 23°C tanto en cultivos líquidos como en placas.155 bacterial strains ^ were introduced from the larval culture water of Pectén maximus ^ which were introduced into Petri dishes with a basal agar-marine medium (5 g / L bacteriological peptone, yeast extract: 1 g / L, ferric citrate strokes and Bacteriological agar: 14 g / L) pH 7.6 characterized by its saline content, and incubated at a temperature of 23 ° C in both liquid and plate cultures.

Estudio de la actividad antibacteriana:Study of antibacterial activity:

Para el estudio de la actividad antibacteriana de esas cepas frente al Vibrio anguillarum se emplearon ensayos de antagonismo por el método de discos y el de microplacas.For the study of the antibacterial activity of these strains against Vibrio anguillarum, antagonism tests were used by the method of discs and microplates.

Para los ensayos de actividad antibacteriana por el método de los discos se emplearon discos de papel de filtro estériles, con un diámetro de 5 mm, se impregnaron con el sobrenadante, y fueron depositados sobre placas de agar previamente sembradas en estrías con el Vibrio anguillarum y posteriormente incubados durante 24-48 h a 23 °C. La actividad se determinó por el halo de inhibición.For the tests of antibacterial activity by the method of the discs sterile filter paper discs, with a diameter of 5 mm, were impregnated with the supernatant, and were deposited on agar plates previously seeded in striations with the Vibrio anguillarum and subsequently incubated for 24-48 h at 23 ° C. The activity was determined by the inhibition halo.

Los ensayos en microplacas en el caldo marino se llevaron a cabo con cultivos puros de las distintas cepas bacterianas y cocultivos de la cepa bacteriana escogida, más la cepa testigo. A cada pocilio de una microplaca de 96 pocilios le fueron añadidos 200 μl de caldo marino y 10 μl de sobrenadantes de diferentes cepas. Finalmente, se añadieron a cada pocilioMicroplate assays in the marine broth were carried out with pure cultures of the different bacterial and coculture strains of the chosen bacterial strain, plus the control strain. To each well of a 96-well microplate, 200 μl of marine broth and 10 μl of supernatants from different strains were added. Finally, they were added to each well

-3 20 μl de la cepa testigo {Vibrio anguillarum) diluida a 10 .- 3 20 μl of the control strain {Vibrio anguillarum) diluted to 10.

Como controles se mantuvieron seis pocilios con 200 μl de caldo marino, tres de ellos inoculados con 10 μl de la cepa bacteriana correspondiente y los otros tres con 20 μl de laAs controls, six wells were maintained with 200 μl of marine broth, three of them inoculated with 10 μl of the corresponding bacterial strain and the other three with 20 μl of the

-3 cepa testigo diluida a 10 . Las microplacas se incubaron durante 24-72 h a una temperatura de 23°C y el grado de inhibición se determinó mediante un lector de Elisa de los distintos pocilios. Los ensayos se hicieron por triplicado.-3 control strain diluted to 10. The microplates were incubated for 24-72 h at a temperature of 23 ° C and the degree of inhibition was determined by an Elisa reader from the different wells. The tests were done in triplicate.

Localizaciόn de la actividad antibacteriana en cultivos puros y cocultivos:Location of antibacterial activity in pure and coculture cultures:

Del estudio de la actividad de todas las cepas bacterianas estudiadas en este trabajo se deduce que solamente las dos cepas denominadas CF-20 (Colección Española de Cultivos Tipo CECT 5719) y C-148 (CECT 5718), son capaces de inhibir el crecimiento del Vibrio anguillarum y por lo tanto seguimos nuestro trabajo solamente sobre estas dos cepas.From the study of the activity of all the bacterial strains studied in this work, it can be deduced that only the two strains named CF-20 (Spanish Crop Type CECT 5719 Collection) and C-148 (CECT 5718), are capable of inhibiting the growth of the Vibrio anguillarum and therefore we continue our work only on these two strains.

En caldo marino (peptona bacteriológica 5 g/L, extracto de levadura: 1 g/L, trazas de citrato férrico y agar bacteriológico: 14 g/L) se llevaron a cabo cultivos puros de las cepasIn marine broth (bacteriological peptone 5 g / L, yeast extract: 1 g / L, traces of ferric citrate and bacteriological agar: 14 g / L) pure cultures of the strains were carried out

C-148, y CF-20 y cocultivos de C-148 y de CF-20 con V. anguillarum. Después de crecer en agitación, durante 48 h, los cultivos y cocultivos se centrifugaron a 2724 G durante 10 min a 4°C. Una vez separado el sobrenadante del precipitado, las células se resuspendieron en un volumen conocido de agua de mar, se rompieron por ultrasonidos (3x1 min, 20 K z) y se lavaron tres veces con agua de mar estéril. Los sobrenadantes del caldo y del lavado del pellet y los lisados se ensayaron con los métodos de discos y el método de microplacas para localizar el efecto antagonista. identificación bacteriana:C-148, and CF-20 and co-cultures of C-148 and CF-20 with V. anguillarum. After growing up under stirring, for 48 h, the cultures and cocultures were centrifuged at 2724 G for 10 min at 4 ° C. Once the supernatant was separated from the precipitate, the cells were resuspended in a known volume of seawater, broken by ultrasound (3x1 min, 20 K z) and washed three times with sterile seawater. The broth supernatants and pellet wash and lysates were tested with the disc methods and the microplate method to locate the antagonistic effect. bacterial identification:

La identificación de las cepas bacterianas objeto de estudio se realizó mediante la determinación de sus características fenotípicas, sistemas multiprueba API-20E y API-20NE y genéticas [extracción del DNA genómico, análisis filogenético de las secuencias del rRNA 16S, RAPD y ensayos de hibridación con sondas: ADN/ADN (DOT BLOT)]. Preparación de cultivos bacterianos de CF-20 y C-148The identification of the bacterial strains under study was determined by determining their phenotypic characteristics, API-20E and API-20NE multi-test systems and genetic [genomic DNA extraction, phylogenetic analysis of 16S rRNA sequences, RAPD and hybridization assays with probes: DNA / DNA (DOT BLOT)]. Preparation of bacterial cultures of CF-20 and C-148

Una colonia de las cepas bacterianas CF-20 o C-148 y otra de V. anguillarum se sembraron y se dejaron crecer en agar marino, se inocularon en cocultivo en matraces de 1.8 L de capacidad con 1200 mL de caldo marino cada uno y se incubaron a 23°C con agitación orbital a 140 r.p.m. durante 24 h.A colony of bacterial strains CF-20 or C-148 and another of V. anguillarum were seeded and grown in marine agar, inoculated in coculture in flasks of 1.8 L capacity with 1200 mL of marine broth each and were incubated at 23 ° C with orbital shaking at 140 rpm for 24 h.

Al cabo de ese tiempo, cuando el crecimiento bacteriano está en fase exponencial, el caldo se centrifuga a 2724 G a 4°C, y los pellets se sonican y se lavan con agua de mar. La capacidad inhibitoria de los sobrenadantes y lisados se comprobó por el método de los discos, utilizando como controles papeles de filtro impregnados en caldo marino. Aislamiento e identificación de las sustancias activas: Extracción y aislamiento:After that time, when the bacterial growth is in exponential phase, the broth is centrifuged at 2724 G at 4 ° C, and the pellets are sonicated and washed with seawater. The inhibitory capacity of the supernatants and lysates was checked by the method of the discs, using as filter controls impregnated in marine broth. Isolation and identification of active substances: Extraction and isolation:

Siguiendo el procedimiento de cultivo descrito anteriormente {Preparación de cultivos bacterianos de CF-20 y C-148), se reúnen los 45 L de sobrenadante del caldo marino procedentes del cocultivo de CF-20 con V. anguillarum, con el sobrenadante de los lisados de los correspondientes pellets, y el volumen total se extrae 3 veces con la mezcla C12CH2: MeOH 75:25. Los extractos se concentraron y se repartieron entre agua y CH2C12 y la fase orgánica concentrada se sometió a separación por cromatografía en columna de gel de sílice eluyendo con mezclas de hexano:AcOEt. Para la localización de la actividad inhibidora al V. anguillarum los procesos de aislamiento y separación, se siguieron por los métodos de discos y microplacas, disolviendo 1 mg de cada fracción en 100 μl de etanol.Following the culture procedure described above {Preparation of bacterial cultures of CF-20 and C-148), the 45 L of supernatant from the marine broth from the co-culture of CF-20 with V. anguillarum are combined with the supernatant of the lysates of the corresponding pellets, and the total volume is extracted 3 times with the mixture C1 2 CH 2 : MeOH 75:25. The extracts were concentrated and partitioned between water and CH 2 C1 2 and the concentrated organic phase was subjected to silica gel column chromatography eluting with hexane mixtures: AcOEt. For the localization of the inhibitory activity to V. anguillarum the isolation and separation processes were followed by the methods of discs and microplates, dissolving 1 mg of each fraction in 100 μl of ethanol.

Las fracciones activas obtenidas de la columna se cromatografiaron por HPLC en una columna serrüpreparativa de fase normal (μ-porasil; hexano:AcOEt 2:3; flujo: 3 mL/min) proporcionando 3.5 mg de Z54 con un tR de 22 min; 4 mg de Z56 con un tR de 29 min; 3 mg Z57 con un tR de 37 y 5 mg de Z59 con un tR de 44 min. Por su parte, de 45 L de sobrenadante de cultivo de la cepa C-148, se extrajeron y cromatografiaron como antes. Las fracciones activas eluidas de la columna de cromatografía proporcionaron un compuesto impuro que se purificó por HPLC en una columna de fase reversa (μ-Bondapak C-18; MeOH:H2O 95:5; flujo: 2 mL/min) dando 3 mg de B717 puro activo con un tR de 17 min y una mezcla que sometida a HPLC en una columna semipreparativa de fase normal (μ-porasil; hexano-AcOEt 2:3; flujo: 3 mL/min) proporcionó importantes compuestos activos frente al Vibrio anguillarum 4 mg de Z54; 3.5 mg de Z56; 3 mg de Z57 y 2.5 mg de Z59. Todos los compuestos mostraron actividad óptica (Tabla 1) y se identificaron como dicetopiperacinas.The active fractions obtained from the column were chromatographed by HPLC on a normal phase serrüpreparative column (μ-porasil; hexane: AcOEt 2: 3; flow: 3 mL / min) providing 3.5 mg of Z54 with a t R of 22 min; 4 mg of Z56 with a t R of 29 min; 3 mg Z57 with a t R of 37 and 5 mg of Z59 with a t R of 44 min. On the other hand, 45 L of culture supernatant of strain C-148, were extracted and chromatographed as before. The active fractions eluted from the chromatography column provided an impure compound that was purified by HPLC on a reverse phase column (μ-Bondapak C-18; MeOH: H 2 O 95: 5; flow: 2 mL / min) giving 3 mg of pure active B717 with a t R of 17 min and a mixture that subjected to HPLC in a semi-preparative column of normal phase (μ-porasil; hexane-AcOEt 2: 3; flow: 3 mL / min) provided important active compounds against to Vibrio anguillarum 4 mg of Z54; 3.5 mg of Z56; 3 mg of Z57 and 2.5 mg of Z59. All compounds showed optical activity (Table 1) and were identified as diketopiperacins.

La elucidación estructural de estos compuestos se llevó a cabo utilizando técnicas deThe structural elucidation of these compounds was carried out using techniques of

13 113 1

RMN (experimentos C, H y DEPT), de masas (e. ; (+) FAB; baja y alta resolución) principalmente, así como por comparación directa con muestras auténticas obtenidas por síntesis. En la Tabla 1 se muestran los datos espectroscópicos más relevantes (13C, 1H y EM).NMR (experiments C, H and DEPT), mass (e.; (+) FAB; low and high resolution) mainly, as well as by direct comparison with authentic samples obtained by synthesis. Table 1 shows the most relevant spectroscopic data ( 13 C, 1H and MS).

Tabla 1: Tiempos de retención t (min), {α}D y fragmentos en el espectrometría de masas de los antibióticos.Table 1: Retention times t (min), {α} D and fragments in antibiotic mass spectrometry.

Figure imgf000005_0001
Figure imgf000005_0001

Síntesis de dicetopiperacinas:Synthesis of diketopiperacins:

Con el objeto de disponer de muestras auténticas de las dicetopiperacinas para comparación directa con las naturales, para ensayos de actividad antibiótica y para la determinación de las características estructurales ligadas a esa actividad, se prepararon por procedimientos conocidos (descritas posteriormente: Preparación de dicetopiperacinas LL y DD) y a partir de los α-aminoácidos correspondientes, una amplia serie de dicetopiperacinas de las series LL y DD que luego se epimerizaron para obtener las correspondientes dicetopiperacinas LD y DL. Preparación de dicetopiperacinas LLy DD:In order to have authentic samples of the diketopiperacins for direct comparison with the natural ones, for antibiotic activity tests and for the determination of the structural characteristics linked to that activity, they were prepared by known procedures (described later: Preparation of diketopiperacins LL and DD) and from the corresponding α-amino acids, a wide series of diketopiperacins of the LL and DD series that were then epimerized to obtain the corresponding dipetopiperacins LD and DL. Preparation of diketopiperacins LL and DD:

Se prepararon primero los dipéptidos protegidos como BOC (butiloxicarbonilo) y metil éster que se ciclaron por calefacción en ácido fórmico/BuOH/Tolueno. De este modo se prepararon las dicetopiperacinas LL y DD de la Tabla 2, excepto la B717 que se obtuvo por acoplamiento entre Cbz-(D)-trans-4-hidroxi-(D)-prolina con (D)-fenilalanina metil éster seguido de N-desprotección por hidrogenación catalítica y ciclación para dar el compuesto B717.Protected dipeptides such as BOC (butyloxycarbonyl) and methyl ester were first prepared and cycled by heating in formic acid / BuOH / Toluene. Thus, the LL and DD diketopiperacins of Table 2 were prepared, except for B717 which was obtained by coupling between Cbz- (D) -trans-4-hydroxy- (D) -proline with (D) -phenylalanine methyl ester followed of N-deprotection by catalytic hydrogenation and cyclization to give compound B717.

Preparación de dicetopiperacinas LD y DL por epimerizaciόn:Preparation of diketopiperacins LD and DL by epimerization:

Se utilizó el procedimiento descrito por Ott et al. 1963 y Adamczeski et al. 1995, con ligeras modificaciones tal y como se describe a continuación:The procedure described by Ott et al. 1963 and Adamczeski et al. 1995, with slight modifications as described below:

En un vial pequeño de vidrio se disuelven 20 mg de dicetopiperacina DD o LL en 0,3 rnL de hidróxido de sodio (0.5 mL de 0.5 N de NaOH en H2O:MeOH, 1:1) y se mantiene durante 15 min a temperatura ambiente. Se añaden algunas gotas de ácido clorhídrico al 15% y se deja toda la noche. La solución se concentra a vacío y el residuo se extrae con cloruro de metileno, se concentra el disolvente y se cristaliza con acetato etilo.In a small glass vial, 20 mg of diketopiperacin DD or LL are dissolved in 0.3 rnL of sodium hydroxide (0.5 mL of 0.5 N NaOH in H 2 O: MeOH, 1: 1) and kept for 15 min at room temperature. A few drops of 15% hydrochloric acid are added and left overnight. The solution is concentrated in vacuo and the residue is extracted with methylene chloride, the solvent is concentrated and crystallized with ethyl acetate.

Concentración mínima inhibidora (CMI) de los antibióticos aislados:Minimum inhibitory concentration (MIC) of isolated antibiotics:

La concentración mínima inhibidora (Civil) de las sustancias activas aisladas Z54, Z56, Z57, Z59 y B717 se determinó mediante el método de dilución de agar descrita en la guía NCCLS (1997), con ligeras modificaciones en la composición del medio, tiempo de incubación y la temperatura. Se prepararon disoluciones de las sustancias activas a distintas concentraciones (0.005; 0,05; 0,1; 0,2; 0,3; 0,4; 0,5; 0,7; 0,8 y 5 μg/mL), y suspensiones de V. anguillarum a distintas diluciones (de 10 a 10 células/mL). A continuación se añaden distintas concentraciones de las sustancias activas sobre placas de Petri previamente sembradas con V. anguillarum y se miden los halos de inhibición al cabo de 24-48 horas. .The minimum inhibitory concentration (Civil) of the isolated active substances Z54, Z56, Z57, Z59 and B717 was determined by the agar dilution method described in the NCCLS guide (1997), with slight modifications in the composition of the medium, time of incubation and temperature. Solutions of the active substances were prepared at different concentrations (0.005; 0.05; 0.1; 0.2; 0.3; 0.4; 0.5; 0.7; 0.8 and 5 μg / mL) , and suspensions of V. anguillarum at different dilutions (from 10 to 10 cells / mL). Different concentrations of the active substances on Petri dishes previously seeded with V. anguillarum are then added and the inhibition halos measured after 24-48 hours. .

Actividad in vivo de las sustancias activas:In vivo activity of active substances:

También se llevaron a cabo estudios in vivo del efecto antibiótico de estas sustancias aisladas Z54, Z56, Z57, Z59 y B717 en diversos cultivos de interés en acuicultura como los de Dicentrarchus labrax, Sparus aurata, Psetta máxima, Maja squiado, Ruditapes decussatus y Ostrea edulis. Se describen a continuación los efectuados con Ruditapes decussatus y Ostrea edulis que son representativos.In vivo studies of the antibiotic effect of these isolated substances Z54, Z56, Z57, Z59 and B717 were also carried out in various crops of interest in aquaculture such as those of Dicentrarchus labrax, Sparus aurata, Psetta maxim, Maja squiado, Ruditapes decussatus and Ostrea Edulis Those carried out with Ruditapes decussatus and Ostrea edulis, which are representative, are described below.

Cultivos larvarios:Larval cultures:

Los cultivos larvarios de Ruditapes decussatus y Ostrea edulis se mantuvieron en el laboratorio a una temperatura controlada de 20°C, renovándose el agua y analizándose la flora bacteriana en general y el V. anguillarum cada dos días. Se llevaron a cabo dos tipos de experimentos: El primero en tubos de 100 mL para hacer una determinación aproximada de la dosis de cada una de las sustancias activas que proporciona el mejor crecimiento y/o supervivencia de las larvas con relación al control, y el segundo en tanques de 70 L para confirmar la actividad y dosis más adecuadas, y acercarse a las condiciones de explotación en acuicultura.The larval cultures of Ruditapes decussatus and Ostrea edulis were kept in the laboratory at a controlled temperature of 20 ° C, the water being renewed and the bacterial flora in general and the V. anguillarum analyzed every two days. Two types of Experiments: The first in 100 mL tubes to make an approximate determination of the dose of each of the active substances that provides the best growth and / or survival of the larvae in relation to the control, and the second in 70 L tanks for confirm the most appropriate activity and dose, and approach the operating conditions in aquaculture.

EXPERIMENTO 1:EXPERIMENT 1:

Para estos experimentos se utilizaron tubos pyrex de 100 mL, conteniendo 90 mL de agua de mar, filtrada a 1 μm y una densidad larvaria de 5-7 larvas.mL" para Ruditapes decussatus y de 1-2 larvas para Ostrea edulis. La edad de las larvas al inicio de los experimentos fue de 3 a 5 días. Los cultivos se mantuvieron con aireación a lo largo de todo el experimento, y se alimentaron con una mezcla de las microalgas Isochrysis galbana (T- iso), Chaetoceros calcitrans, Pavlova lutheri y Tetraselmis suecica (20:10:20:5 células. μL"1, respectivamente).For these experiments, 100 mL pyrex tubes were used, containing 90 mL of seawater, filtered at 1 μm and a larval density of 5-7 larvae " for Ruditapes decussatus and 1-2 larvae for Ostrea edulis. Age of the larvae at the beginning of the experiments was 3 to 5 days.The cultures were maintained with aeration throughout the experiment, and fed with a mixture of the microalgae Isochrysis galbana (T-iso), Chaetoceros calcitrans, Pavlova Lutheri and Tetraselmis Suecica (20: 10: 20: 5 cells. μL "1 , respectively).

A estos cultivos se añadieron distintas concentraciones (0.005; 0.05; 0.1; 0.2; 0.3; 0.4; 0.5; 0.7; 0.8 y 5 μg/mL) de cada una de las sustancias activas, y se determinó la dosis de cada sustancia, que permite el mejor crecimiento y/o supervivencia de las larvas, medido a los 22 días de iniciado el cultivo. EXPERIMENTO 2:To these cultures were added different concentrations (0.005; 0.05; 0.1; 0.2; 0.3; 0.4; 0.5; 0.7; 0.8 and 5 μg / mL) of each of the active substances, and the dose of each substance was determined, which allows the best growth and / or survival of the larvae, measured 22 days after the start of the culture. EXPERIMENT 2:

Una vez determinada la dosis adecuada de cada sustancia según el método descrito en el experimento 1, se comprobó el efecto de las sustancias activas en cultivos larvarios contenidos en tanques de 70 L, manteniendo las mismas condiciones experimentales del experimento 1, excepto que el contaje de las larvas se realizó a los 11 días de la adición de las sustancias.Once the appropriate dose of each substance was determined according to the method described in experiment 1, the effect of the active substances in larval cultures contained in 70 L tanks was checked, maintaining the same experimental conditions of experiment 1, except that the counting of The larvae were performed 11 days after the addition of the substances.

Mortalidad, crecimiento larvario y flora bacteriana:Mortality, larval growth and bacterial flora:

Para la determinación de la mortalidad y del crecimiento larvario después de la adición de las sustancias antibióticas aisladas (Z54, Z56, Z57, Z59 y B717), las larvas procedentes de los experimentos anteriores fueron recogidas en tamices, y se suspendieron en un pequeño volumen de agua de mar, del que se tomaron tres alícuotas de 100 μL que fueron examinadas para la estimación del número media de larvas y el cálculo de la supervivencia. Para analizar la evolución de los vibrios y flora bacteriana en general, tras la adición de las sustancias antibióticas, se tomaron muestras de 1 mL de cultivo que fueron diluidas con agua de mar estéril hasta una dilución de 10" . Alícuotas de 40 mL de estas diluciones se sembraron por duplicado en agar marino Z2216 (Difco) y agar Tiosulfato-Citrato-Bilis- Sacarosa (TCBS) (Oxoid). Las placas de cultivo de agar marino se incubaron a 23°C, durante 2-4 días, y las de TCBS durante 2 días. Al cabo de este tiempo se calcularon las unidades viables (UFC: Unidades Formadoras de Colonias) multiplicando la media del número de colonias por el inverso del factor de dilución. Del estudio de la actividad de todas las cepas bacterianas presentes en los cultivos de vieira, dorada y ostra plana se deduce que solamente las dos cepas denominadas CF-20 y C- 148 son capaces de inhibir el crecimiento del Vibrio anguillarum. Además, se comprueba que esa actividad sólo se produce cuando cualquiera de esas dos cepas bacterianas está en contacto directo con el V. anguillarum. Cuando se llevaron a cabo ensayos separados para el pellet y el sobrenadante de cultivos de CF-20 y C-148 los resultados de actividad indican claramente que las sustancias antibióticas están presentes en el sobrenadante y en el pellet de las células.For the determination of mortality and larval growth after the addition of the isolated antibiotic substances (Z54, Z56, Z57, Z59 and B717), the larvae from the previous experiments were collected in sieves, and suspended in a small volume of seawater, from which three 100 μL aliquots were taken and examined for the estimation of the average number of larvae and the calculation of survival. To analyze the evolution of the vibrios and bacterial flora in general, after the addition of the antibiotic substances, samples of 1 mL of culture were taken that were diluted with sterile seawater to a dilution of 10 " . 40 mL aliquots of these dilutions were seeded in duplicate on Z2216 marine agar (Difco) and Thiosulfate-Citrate-Bile- agar Sucrose (TCBS) (Oxoid). The marine agar culture plates were incubated at 23 ° C, for 2-4 days, and those of TCBS for 2 days. After this time, the viable units (CFU: Colony Forming Units) were calculated by multiplying the average number of colonies by the inverse of the dilution factor. From the study of the activity of all bacterial strains present in scallop, sea bream and flat oyster cultures, it can be deduced that only the two strains called CF-20 and C-148 are capable of inhibiting the growth of Vibrio anguillarum. In addition, it is verified that this activity only occurs when either of these two bacterial strains is in direct contact with V. anguillarum. When separate assays for the pellet and culture supernatant of CF-20 and C-148 were carried out the activity results clearly indicate that antibiotic substances are present in the supernatant and in the cell pellet.

El estudio de sus características fenotípicas, sistemas multipmeba API-20E Y API- 20NE y genéticas, identifican a las cepas CF-20 como Roseobacter galleaciensis sp y C-148 como Roseobacter sp.The study of its phenotypic characteristics, multipmeba API-20E and API-20NE and genetic systems, identify CF-20 strains as Roseobacter galleaciensis sp and C-148 as Roseobacter sp.

Cultivos de las cepas CF-20 y C-148:Cultures of CF-20 and C-148 strains:

Con el objeto de aislar e identificar las sustancias activas frente al Vibrio anguillarum, y obtenerlas en cantidad suficiente, se llevaron a cabo en primer lugar, una serie de cultivos en pequeña escala para determinar las mejores condiciones experimentales para el cultivo de las cepas activas y la producción de los antibióticos así como el momento en el que la concentración es máxima. De los resultados, se dedujo que el cultivo en caldo marino (peptona: 5 g/L, extracto de levadura: 1 g/L y citratos férricos) a 23°C, con agitación orbital (140 r.p.m) durante 24 horas y en cocultivo de la cepa CF-20 o C-148 y el Vibrio anguillarum eran las condiciones más favorables. Con esa información se establecieron cocultivos de las cepas CF-20 y C-148 con elIn order to isolate and identify the active substances against Vibrio anguillarum, and obtain them in sufficient quantity, a series of small-scale cultures were first carried out to determine the best experimental conditions for the cultivation of the active strains and the production of antibiotics as well as the moment in which the concentration is maximum. From the results, it was deduced that the culture in marine broth (peptone: 5 g / L, yeast extract: 1 g / L and ferric citrates) at 23 ° C, with orbital agitation (140 rpm) for 24 hours and in coculture of the CF-20 or C-148 strain and Vibrio anguillarum were the most favorable conditions. With this information, co-cultures of strains CF-20 and C-148 were established with the

Vibrio anguillarum en matraces de 1.8 L que fueron utilizados para la extracción de las sustancias activas frente al Vibrio anguillarum a partir del sobrenadante del caldo y de los lisados de las células en los que previamente habíamos localizado la actividad. Aislamiento, estructura y síntesis de los antibióticos: Aislamiento:Vibrio anguillarum in 1.8 L flasks that were used for the extraction of active substances against Vibrio anguillarum from the broth supernatant and cell lysates in which we had previously located the activity. Isolation, structure and synthesis of antibiotics: Isolation:

Los procesos de extracción, separación y aislamiento, se siguieron por medio de los test de actividad en discos y microplacas. Así, por extracción selectiva del caldo y los lisados de los cocultivos de CF-20 y C-148 se obtuvo un extracto activo frente al Vibrio anguillarum cuya fracción soluble en diclorometano, fue sometida a separación cromatográfica en silica gel que proporcionó varias fracciones activas de las que finalmente se aislaron por HPLC cantidades de 3-5 mg de los componentes activos frente al Vibrio anguillarum puros.The extraction, separation and isolation processes were followed through the activity tests on disks and microplates. Thus, by selective extraction of the broth and lysates of the co-cultures of CF-20 and C-148, an active extract was obtained against Vibrio anguillarum whose fraction soluble in dichloromethane, was subjected to chromatographic separation on silica gel that provided several active fractions from which finally 3-5 mg of the active components were isolated by HPLC against the pure Vibrio anguillarum.

De la cepa bacteriana CF-20 se obtuvieron los cuatro compuestos: Z54, Z56, Z57 y Z59, mientras que los extractos de la cepa C-148 proporcionaron además de esos mismos cuatro componentes, en cantidades similares, un nuevo componente activo B717.From the bacterial strain CF-20, the four compounds were obtained: Z54, Z56, Z57 and Z59, while extracts of strain C-148 provided in addition to those same four components, in similar amounts, a new active component B717.

El estudio estructural de estos compuestos llevado a cabo por métodos espectroscópicos (RMN y EM principalmente), muestran para Z54, Z56, Z57, Z59 la presencia de señales en el RMN de protón y carbono características de dicetopiperacinas que contienen el anillo de Pro fusionado con Leu, He, Val y Phe. Los espectros de masas por impacto electrónico y FAB de baja y alta resolución confirman esas estructuras. Por su parte, el compuesto B717, presenta unas características espectroscópicas similares a las de Z59 pero contiene 4-hidroxiprolina en lugar de prolina. Los datos espectroscópicos mencionados indican además que los dos centros asimétricos de las cinco dicetopiperacinas presentan la misma configuración, (LL o DD) y son coincidentes con los descritos para ciclo(L)-prolina- (L)-Leucina (Pickenhagen et al. 1975; Paul et al. 1976; Schmitz et al. 1983; Adamczeski et al. 1995; Ginz et al. 2000), ciclo(L)-prolina-(L)-Isoleucina (Adamczeski et al 1995; Ginz et al 2000), ciclo(L)-prolina-(L)-valina (Paul et al. 1976; Schmitz et al 1983; Adamczeski et al 1995 y Ginz et al 2000), ciclo(L)-prolina-(L)-fenilalanina (Pickenhagen et al. 1975; Paul et al. 1976; Adamczeski et al. 1995 y Ginz et al. 2000), y ciclo(L)-trans-4-hidroxiprolinil-(L)- fenilalanina (Adamczeski et al. 1989; Young et al. 1976; Trigos et al. 1997; Jayatilake et al. 1996; Ginz et al. 2000), pero los valores de poder rotatorio de nuestros compuestos indican que se trata de los correspondientes enantiómeros. Síntesis de antibióticos aislados: Se prepararon, utilizando procedimientos comunes (descritos anteriormente en Síntesis de dicetopiperacinas) a partir de alfa aminoácidos, las correspondientes dicetopiperacinas con estereoquímica LL y DD. Por epimerización de las anteriores se obtuvieron las correspondientes dicetopiperacinas con estereoquímica LD y DL. La comparación directa demostró que las naturales son los enantiómeros DD. Así pues Z54 es ciclo(D)-prolina-(D)-Isoleucma, Z56 es ciclo(D)-prolina-(D)-Leucina, Z57 es ciclo(D)- prolina-(D)-valina, Z59 es ciclo(D)-prolina-(D)-fenilalanina, y B717 es ciclo(D)-trans-4- droxiprolinil-(D)-fenilalarιina. ESTRUCTURAS DE LOS COMPUESTOS AISLADOSThe structural study of these compounds carried out by spectroscopic methods (NMR and MS mainly), show for Z54, Z56, Z57, Z59 the presence of signals in the proton and carbon NMR characteristics of diketopiperacins containing the Pro ring fused with Leu, He, Val and Phe. The low and high resolution electronic impact and FAB mass spectra confirm these structures. For its part, compound B717, has spectroscopic characteristics similar to those of Z59 but contains 4-hydroxyproline instead of proline. The spectroscopic data mentioned further indicate that the two asymmetric centers of the five diketopiperacins have the same configuration, (LL or DD) and are consistent with those described for cycle (L) -proline- (L) -Leucine (Pickenhagen et al. 1975 ; Paul et al. 1976; Schmitz et al. 1983; Adamczeski et al. 1995; Ginz et al. 2000), cycle (L) -proline- (L) -Isoucine (Adamczeski et al 1995; Ginz et al 2000), cycle (L) -proline- (L) -valine (Paul et al. 1976; Schmitz et al 1983; Adamczeski et al 1995 and Ginz et al 2000), cycle (L) -proline- (L) -phenylalanine (Pickenhagen et al. 1975; Paul et al. 1976; Adamczeski et al. 1995 and Ginz et al. 2000), and cycle (L) -trans-4-hydroxypropyl- (L) - phenylalanine (Adamczeski et al. 1989; Young et al 1976; Trigos et al. 1997; Jayatilake et al. 1996; Ginz et al. 2000), but the rotational power values of our compounds indicate that they are the corresponding enantiomers. Synthesis of isolated antibiotics: The corresponding diketopiperacins with stereochemistry LL and DD were prepared using common procedures (described above in Synthesis of diketopiperacins) from alpha amino acids. By epimerization of the above, the corresponding diketopiperacins with stereochemistry LD and DL were obtained. The direct comparison showed that the natural ones are the DD enantiomers. Thus Z54 is cycle (D) -proline- (D) -Isoleucma, Z56 is cycle (D) -proline- (D) -Leucine, Z57 is cycle (D) - proline- (D) -valine, Z59 is cycle (D) -proline- (D) -phenylalanine, and B717 is cyclo (D) -trans-4-droxypropyl- (D) -phenylalarine. STRUCTURES OF ISOLATED COMPOUNDS

Figure imgf000010_0001
Figure imgf000010_0001

Ciclo(D-pro-D-phe): Z59Cycle (D-pro-D-phe): Z59

Figure imgf000010_0002
ciclo(D)-pro-(D)-Leu: Z54 ciclo(D)-pro-(D)-val: Z57
Figure imgf000010_0002
cycle (D) -pro- (D) -Leu: Z54 cycle (D) -pro- (D) -val: Z57

Figure imgf000010_0003
Figure imgf000010_0003

Ciclo(D)-tr-ms-4-hidroxiproliml-D-fenilalaninaCycle (D) -tr-ms-4-hydroxypropyll-D-phenylalanine

B717 ciclo(D)-pro-(D)-Ile: Z56B717 cycle (D) -pro- (D) -Ile: Z56

En las tablas 1, 3 y 4 se muestran los datos de RMN de protón, carbono y de E. de masas de los antibióticos aislados de las cepas bacterianas.Tables 1, 3 and 4 show the proton, carbon and E. mass NMR data of antibiotics isolated from bacterial strains.

Actividad antibiόtica de las dicetopiperacinas naturales y sintéticas: La síntesis de dicetopiperacinas con estereoquímica diversa, a partir de alfa aminoácidos permitió disponer de una amplia colección de compuestos que fueron sometidos a ensayos de su actividad antibiótica junto con las muestras naturales (Tabla 2).Antibiotic activity of natural and synthetic diketopiperacins: The synthesis of diketopiperacins with diverse stereochemistry, from alpha amino acids, allowed us to have a wide collection of compounds that were subjected to tests of their antibiotic activity together with natural samples (Table 2).

Todos los antibióticos naturales (Z54, Z56, Z57, Z59 y B717) aislados de ambas cepas bacterianas CF-20 y C-148 han mostrado una fuerte actividad frente a los Vibrios y la flora bacteriana en general, que justifica el efecto encontrado en los cultivos larvarios iniciales. Los ensayos in vitro muestran una actividad (0,03 < CMI < 0,07 Tabla 2), comparable o superior a la de algunos de los antibióticos utilizados actualmente en acuicultura como la oxitetraciclina (CMI: 0.5 μg.mL"1).All natural antibiotics (Z54, Z56, Z57, Z59 and B717) isolated from both bacterial strains CF-20 and C-148 have shown strong activity against Vibrios and bacterial flora in general, which justifies the effect found in the initial larval cultures. In vitro tests show an activity (0.03 <MIC <0.07 Table 2), comparable or superior to that of some of the antibiotics currently used in aquaculture such as oxytetracycline (MIC: 0.5 μg.mL "1 ).

El estudio sistemático de la actividad antibiótica de la colección de dicetopiperacinas sintetizadas y de las naturales, muestra que la actividad esta ligada esencialmente a la estereoquímica de compuesto y que en general, los isómeros DD son unas 2 veces más activos que los LD y DL mientras que los isómeros LL son prácticamente inactivos.The systematic study of the antibiotic activity of the collection of synthesized and natural diketopiperacins, shows that the activity is essentially linked to the stereochemistry of the compound and that in general, the DD isomers are about 2 times more active than the LD and DL while that LL isomers are practically inactive.

Tabla 2: Concentración míi ima üihibitoria (CMI; μg.mL"1) frente al V. anguillarum de una selección de dicetopiperacinas con estereoquímica DD, LD y DL.Table 2: Mimic ima inhibitory concentration (MIC; μg.mL "1 ) against V. anguillarum of a selection of diketopiperacins with stereochemistry DD, LD and DL.

Figure imgf000011_0001
11
Figure imgf000011_0001
eleven

Cuando las sustancias antibióticas activas fueron ensayadas in vivo, pudo comprobarse que esa actividad se mantiene y que producen una clara redución de la flora bacteriana total y de la de los Vibrios y que mejoran la supervivencia de las especies cultivadas en el tanque. A modo de ejemplo se muestra en el Gráfico 3 el resultado de los ensayos in vivo con larvas del molusco Ruditapes decussatus, de las dicetopiperacinas naturales aisladas de las cepas CF-20 y C-148. En estos experimentos, se observa que la supervivencia de las larvas aumenta en valores que van desde el 12 al 33%, siendo el compuesto más activo el Z59 y el menos activo B717, no habiendo diferencias esenciales en la actividad de los otros que se mantienen en torno al 20%.When the active antibiotic substances were tested in vivo, it could be verified that this activity is maintained and that they produce a clear reduction of the total bacterial flora and that of the Vibrios and that they improve the survival of the species grown in the tank. As an example, Figure 3 shows the results of in vivo tests with larvae of Ruditapes decussatus mollusc, of the natural diketopiperacins isolated from strains CF-20 and C-148. In these experiments, it is observed that the survival of the larvae increases in values ranging from 12 to 33%, the most active compound being Z59 and the least active B717, there being no essential differences in the activity of the others that remain around 20%.

La elevada mortalidad en los tanques de control muestra claramente que la flora bacteriana es la principal causa de mortalidad de las larvas tal y como indican los valores obtenidos para UFC y los cambios observados en la flora bacteriana en general y en los Vibrio.The high mortality in the control tanks clearly shows that the bacterial flora is the main cause of mortality of the larvae, as indicated by the values obtained for CFU and the observed changes in bacterial flora in general and in Vibrio.

Ensayos in vivoIn vivo essays

D supervivenciaD survival

Figure imgf000012_0001
Figure imgf000012_0001

Z57 Z59 Z54 Z56 B717 (0,5) (0,5) (0,5) (0,5) (0,5) sustancias añadidas (μg.mL"1)Z57 Z59 Z54 Z56 B717 (0.5) (0.5) (0.5) (0.5) (0.5) substances added (μg.mL "1 )

Gráfico 3: Ensayos de actividad in vivo frente a Ruditapes decussatusGraph 3: In vivo activity tests against Ruditapes decussatus

En realidad, la actividad antibiótica de estas sustancias es tan intensa que en cultivos tratados con los antibióticos a concentraciones tan bajas como 0,5 ppm., los Vibrios se reducen en más del 70%. El efecto protector que la adición de estas sustancias tiene sobre los cultivos larvarios se pone claramente de manifiesto por el hecho de que las larvas de los cultivos no tratados con los antibióticos no sobrevivieron más de cuatro días. En contraste con lo descrito para antibióticos comerciales como cloramfenicol, florfenicol, flumequina y trimetoprim/sulfadiazina, nuestros ensayos in vivo muestran que las dicetopiperacinas activas no pierden su actividad por los cambios de salinidad y temperatura (Christian. 2001) del medio, asociados al paso de ensayos in vitro a in vivo. Procedimiento para la utilización de los antibióticos:In fact, the antibiotic activity of these substances is so intense that in cultures treated with antibiotics at concentrations as low as 0.5 ppm., Vibrios are reduced by more than 70%. The protective effect that the addition of these substances has on larval cultures is clearly evidenced by the fact that the larvae of cultures not treated with antibiotics did not survive more than four days. In contrast to that described for commercial antibiotics such as chloramphenicol, florfenicol, flumequina and trimethoprim / sulfadiazine, our in vivo tests show that active diketopiperacins do not lose their activity due to changes in salinity and temperature (Christian. 2001) of the medium, associated with the passage from in vitro to in vivo assays. Procedure for the use of antibiotics:

Tratamiento de moluscos:Mollusc treatment:

Una solución conteniendo el antibiótico o mezcla de los antibióticos descritos, naturales y sintéticos, se añade al tanque al inicio del cultivo larvario de manera que la concentración final sea de 0.5-1 μg/mL. Al cabo de dos días se renueva el agua del tanque y se repone la solución antibiótica restableciéndose la concentración inicial. El proceso de renovación del agua y adición de los antibióticos se repite hasta un total de cinco veces. Al cabo de ese tiempo, (10 días) se da por finalizado el tratamiento. Tratamiento de peces y crustáceos:A solution containing the antibiotic or mixture of the described natural and synthetic antibiotics is added to the tank at the beginning of the larval culture so that the final concentration is 0.5-1 μg / mL. After two days the water in the tank is renewed and the antibiotic solution is replenished, restoring the initial concentration. The process of water renewal and the addition of antibiotics is repeated up to a total of five times. After that time, (10 days) the treatment is terminated. Fish and crustacean treatment:

1) Para cultivos con circulación de agua en sistema cerrado, se disminuye el agua del tanque al mínimo nivel que no afecte a las especies cultivadas, y se añade el antibiótico hasta alcanzar la concentración final antes indicada, dejándolo actuar durante 30 min con agitación y al cabo de ese tiempo, se restaura el nivel normal de agua. Este tratamiento se repite cada dos días hasta un total de entre 4-5 veces (8-10 días de tratamiento).1) For crops with water circulation in a closed system, the water in the tank is reduced to the minimum level that does not affect the cultivated species, and the antibiotic is added until reaching the final concentration indicated above, leaving it to act for 30 min with stirring and after that time, the normal water level is restored. This treatment is repeated every two days for a total of 4-5 times (8-10 days of treatment).

2) Para cultivos en los que el agua circule en un sistema abierto, se para el suministro de agua durante 30 min, se baja el nivel hasta el mínimo que no afecte a las especies cultivadas y se añade el antibiótico como en el caso anterior. Pasados los 30 min se restablece la circulación de agua normal. Este proceso se repite cada dos días hasta un total de 4-5 veces (8-10 días de tratamiento). 2) For crops in which the water circulates in an open system, the water supply is stopped for 30 min, the level is lowered to the minimum that does not affect the cultivated species and the antibiotic is added as in the previous case. After 30 min the normal water circulation is restored. This process is repeated every two days up to a total of 4-5 times (8-10 days of treatment).

Tabla 3: Datos 13C-RMN (CDC13, 300 MHz) de los antibióticos aislados de las cepas bacterianas: CF-20 y C-148Table 3: 13 C-NMR (CDC1 3 , 300 MHz) data of antibiotics isolated from bacterial strains: CF-20 and C-148

Figure imgf000014_0001
Figure imgf000014_0001

Tabla. 4: Datos 1H-RMN (CDC13, 300 MHz) de los antibióticos aislados de las cepas bacterianas: CF-20 y C-148:Table. 4: 1H-NMR data (CDC1 3 , 300 MHz) of antibiotics isolated from bacterial strains: CF-20 and C-148:

Figure imgf000015_0001
Figure imgf000015_0001

Tabla. 4 (Continuación):Table. 4 (Continued):

Figure imgf000016_0001
Figure imgf000016_0001

REFERENCIAS:REFERENCES:

Adamczeski, M.; Reed, A.R. y P. Crews. (1995). Knew and Known Diketopiperazines from the Caribbean Sponge, Galxy CF. podatypa. Journal of Natural Product, 58(2): 201-208.Adamczeski, M .; Reed, A.R. and P. Crews. (nineteen ninety five). Knew and Known Diketopiperazines from the Caribbean Sponge, Galxy CF. podatypa Journal of Natural Product, 58 (2): 201-208.

Alderman, D. . y Michel, C. (1992). Chemotherapy in aquaculture today. En: Michel, C. yAlderman, D.. and Michel, C. (1992). Chemotherapy in aquaculture today. In: Michel, C. and

Alderman, D.J. (Eds.), Chemotherapy m Aquaculture: From Theory to Reality. OfficeAlderman, D.J. (Eds.), Chemotherapy m Aquaculture: From Theory to Reality. Office

International des Epizootics, París, pp. 3-24.International des Epizootics, Paris, pp. 3-24.

Baticados, M.C.L.; La Villa-Pitogo, C.R.; Cruz-Lacierda, E.R.; De La Peña, R.E. y N.A. Sunaz. (1990). Studies on the chemical control of luminous bacteria V. harveyi and V. splendiuds isolated from diseased Penaeus monodon larvae and rearing water. Dis. aquat.Baticados, M.C.L .; La Villa-Pitogo, C.R .; Cruz-Lacierda, E.R .; De La Peña, R.E. and N.A. Sunaz (1990). Studies on the chemical control of luminous bacteria V. harveyi and V. splendiuds isolated from diseased Penaeus monodon larvae and rearing water. Dis. aquat

Org., 9:133-139. Castro, D.; Martínez-Manzanares, E.; Fouz, A.B.; Moriñigo, M.A.; Borrego, J.J. y A.E.Org., 9: 133-139. Castro, D .; Martínez-Manzanares, E .; Fouz, AB; Moriñigo, MA; Borrego, JJ and AE

Toranzo. (1992). Characterization of strains related to brown ring disease outbreaks in southwestem Spain. Dis. aquat. Org., 14: 229-236.Toranzo (1992). Characterization of strains related to brown ring disease outbreaks in southwestem Spain. Dis. aquat Org., 14: 229-236.

Christian. M. y Guillaume. B. (2001). Minimal inhibitory concentration methodology in aquaculture : the temperature effect. Aquaculture 196, 311-318.Christian M. and Guillaume. B. (2001). Minimal inhibitory concentration methodology in aquaculture: the temperature effect. Aquaculture 196, 311-318.

Ginz, M. y Engelhardt, U.H. (2000). Identification of Proline-Based Diketopiperazines inGinz, M. and Engelhardt, U.H. (2000). Identification of Proline-Based Diketopiperazines in

Roasted Coffee. J Agrie. Food. Chem., 48: 3528-3532.Roasted Coffee J Agrie. Food. Chem., 48: 3528-3532.

Jayatilake, G.S.; Thornton, M.P.; Leonard, A.C.; Grimwade, J.E. y Baker, B.J. (1996).Jayatilake, G.S .; Thornton, M.P .; Leonard, A.C .; Grimwade, J.E. and Baker, B.J. (nineteen ninety six).

Metabolites from an Antarctic Sponge-Associated Bacterium, Pseudomonas aeruginosa. J. Nat. Prod., 59: 293-296.Metabolites from an Antarctic Sponge-Associated Bacterium, Pseudomonas aeruginosa. J. Nat. Prod., 59: 293-296.

Masumura, K.; Yasunobu, H.; Okada, Ν. y Muroga, K. (1989). Isolation of a Vibrio sp., the causative bacterium of intestinal necrosis of Japanese lounder larvae. Fish Pathoi, 24: 135-Masumura, K .; Yasunobu, H .; Okada, Ν. and Muroga, K. (1989). Isolation of a Vibrio sp., The causative bacterium of intestinal necrosis of Japanese lounder larvae. Fish Pathoi, 24: 135-

141.141.

Myhr, E.; Larsen, J.L.; Lillehaug, A.; Gudding, R.; Heum, M. y Hastein, T. (1991). Characterization of Vibrio anguillarum and closely related species isolated from farmed fish in Νorway. Appl. Environ. Microbiol., 57: 2750-2757.Myhr, E .; Larsen, J.L .; Lillehaug, A .; Gudding, R .; Heum, M. and Hastein, T. (1991). Characterization of Vibrio anguillarum and closely related species isolated from farmed fish in Νorway. Appl. Environ. Microbiol., 57: 2750-2757.

ΝCCLS, (1997). Performance Standards for Antimicrobial Disk and Dilution SusceptibilityΝCCLS, (1997). Performance Standards for Antimicrobial Disk and Dilution Susceptibility

Tests for Bacteria isolated from Animáis; Tentative Standard. ΝCCLS Document M31-T.Tests for Bacteria isolated from Animáis; Tentative Standard ΝCCLS Document M31-T.

Nicolás, J.L.; Corre, S.; Robert, R. y Ansquer, D. (1995). Why do scallop (Pectén maximus) larvae die, when they are reared without antibiotics?. 1O International Pectinid Workshop.Nicolás, J.L .; Run, S .; Robert, R. and Ansquer, D. (1995). Why do scallop (Pectén maximus) larvae die, when they are reared without antibiotics ?. 1O International Pectinid Workshop.

Cork (Ireland). 27 de Abril- 2 de Mayo, 1995.Cork (Ireland). April 27 - May 2, 1995.

Nogami, K. Maeda, M. (1992). Bacteria as biocontrol agents for rearing larvea of the crabNogami, K. Maeda, M. (1992). Bacteria as biocontrol agents for rearing larvea of the crab

Portunus trituberculatus. Can. J. Fish. Aquat. Sci., 49: 2373-2376.Portunus trituberculatus. Dog. J. Fish Aquat Sci., 49: 2373-2376.

Ott. H; Frey, A. J. ; Hoffman, A. (1963). Tetrahedron 19, 1675 (1963). Paillard, C. y Maes, P. (1990). Etiologie de la maladie de lánneau brun chez Tapes philippinarum : Pathogénicité d'un vibrio sp. C. R. Acad. Sci., Paris 310: 15-20.Ott. H; Frey, A. J.; Hoffman, A. (1963). Tetrahedron 19, 1675 (1963). Paillard, C. and Maes, P. (1990). Etiologie de la maladie de lánneau brun chez Tapes philippinarum: Pathogénicité d'un vibrio sp. C. R. Acad. Sci., Paris 310: 15-20.

Paul e. Young, Vicent Madison, and Elkan R. Blout. Cyclic Peptides. 15 Lanthanide-AssistedPaul e. Young, Vicent Madison, and Elkan R. Blout. Cyclic Peptides 15 Lanthanide-Assisted

13C and JH NMR Analysis of Preferred Side-Chain Rotamers in Proline-Containing Cyclic 13 C and J H NMR Analysis of Preferred Side-Chain Rotamers in Proline-Containing Cyclic

Dipeptides. Journal of the American Chemical Society /98:17/ August 18, 1976. 5365-5371. Pickenhagen, W.; Dietrich, P.; Polonsky, J. Nouaille, F. y Lederer, E. (1975). Identification of the Bitter Principal of Cocoa. Helvética ChimicaActa, 58, Fase. 4(115): 1078-1086.Dipeptides Journal of the American Chemical Society / 98: 17 / August 18, 1976. 5365-5371. Pickenhagen, W .; Dietrich, P .; Polonsky, J. Nouaille, F. and Lederer, E. (1975). Identification of the Bitter Principal of Cocoa. Helvetica ChimicaActa, 58, Phase. 4 (115): 1078-1086.

Schrnitz, F.J.; VanderaH, D.J.; Hollenbeak, K.H.; Enwall, C.E.L. y Gopich-md, Y. (1983).Schrnitz, F.J .; VanderaH, D.J .; Hollenbeak, K.H .; Enwall, C.E.L. and Gopich-md, Y. (1983).

Metabolites from the Marine Sponge Tedania ignis. A new Atisanediol and Several knownMetabolites from the Marine Sponge Tedania ignis. A new Atisanediol and Several known

Diketopiperazines. J. Org. Chem., 48: 3941-3945. Toranzo, A.E.; Santos, I.; Lemos, M.L.; Ledo, A. y Bolinches, J. (1987). Homology of Vibrio anguillarum strains causing epizootics in turbot, salmón and trout reared on the Atlantic Coast of Spain. Aquaculture, 67: 41-52.Diketopiperazines. J. Org. Chem., 48: 3941-3945. Toranzo, AE; Santos, I .; Lemos, ML; Ledo, A. and Bolinches, J. (1987). Homology of Vibrio anguillarum strains causing epizootics in turbot, salmon and trout reared on the Atlantic Coast of Spain. Aquaculture, 67: 41-52.

Toranzo, A.E. y Barja, J.L. (1990). A review of the taxonomy and Seroepizootiology of Vibrio anguillarum, with special reference to aquaculture in northwest of Spain. Dis. Aquat. Org., 9: 73-82.Toranzo, A.E. and Barja, J.L. (1990). A review of the taxonomy and Seroepizootiology of Vibrio anguillarum, with special reference to aquaculture in northwest of Spain. Dis. Aquat Org., 9: 73-82.

Trigos, A.; Reyna, S.; Galindo, G. y Ramos, J.M. (1996). Diketopiperazines from cultures of Fungus Pestalotia palmarum. Natural Product letters, 8: 199-205.Wheats, A .; Queens.; Galindo, G. and Ramos, J.M. (nineteen ninety six). Diketopiperazines from cultures of Fungus Pestalotia palmarum. Natural Product letters, 8: 199-205.

Young, P.E.; Madison, V. y Blout, E.R. (1976). Cyclic Peptides. 15 Lanthanide-Assisted 13C and JH NMR Analysis of Preferred Side-Chain Rotamers in Proline-Containing Cyclic Dipeptides. JACS , 98: 5365-5371. Young, PE; Madison, V. and Blout, ER (1976). Cyclic Peptides 15 Lanthanide-Assisted 13 C and J H NMR Analysis of Preferred Side-Chain Rotamers in Proline-Containing Cyclic Dipeptides. JACS, 98: 5365-5371.

Claims

REIVINDICACIONES 1.- Nuevos antibióticos activos, y sus análogos sintéticos, frente al Vibrio anguillarum obtenidos a partir de cepas bacterianas cultivadas, y sus aplicaciones en cultivo de peces, crustáceos, moluscos y otras actividades de acuicultura. 1.- New active antibiotics, and their synthetic analogues, against Vibrio anguillarum obtained from cultured bacterial strains, and their applications in fish culture, crustaceans, molluscs and other aquaculture activities. 2.- Las cepas bacterianas CF-20 {Roseobacter galleaciensis sp) y C-148 {Roseobacter sp.), depositadas en la Colección Española de Cultivos Tipo con el número CECT 5719 y CECT 5718, respectivamente, y caracterizadas por:2.- The bacterial strains CF-20 {Roseobacter galleaciensis sp) and C-148 {Roseobacter sp.), Deposited in the Spanish Type Culture Collection with the number CECT 5719 and CECT 5718, respectively, and characterized by: - Ser bacilos con colonias marrones, Gram negativas, y móviles;- Be bacilli with brown colonies, Gram negative, and mobile; - Su perfil RAPD y su hibridación con DNA de otras especies del género Roseobacter, - No presentar, actividad de arginina dehidrolasa, lisina descarboxilasa, ni gelatinasa;- Its RAPD profile and its hybridization with DNA of other species of the genus Roseobacter, - Not presenting, arginine dehydrolase activity, lysine decarboxylase, or gelatinase; - Ser la cepa C-148 sensible a la Ampicilina, LincoSpectina y Norfloxacina.- Be the strain C-148 sensitive to Ampicillin, LincoSpectin and Norfloxacin. 3.- Procedimiento de cultivo de las cepas bacterianas CF-20 y C-148, según la reivindicación 2, caracterizado por el cultivo puro de las cepas y en cocultivo de esas cepas con V. anguillarum en matraces de 1.8 L con caldo marino compuesto de extracto de levadura, peptona y trazas de citrato férrico, a temperaturas de entre 4° y 35°C y pH de entre 4 y 10, con agitación orbital durante 24 horas.3. Method of cultivation of the bacterial strains CF-20 and C-148, according to claim 2, characterized by the pure culture of the strains and in coculture of these strains with V. anguillarum in 1.8 L flasks with compound marine broth of yeast extract, peptone and traces of ferric citrate, at temperatures between 4 ° and 35 ° C and pH between 4 and 10, with orbital agitation for 24 hours. 4.- Procedimiento de obtención de los antibióticos, a partir de las cepas cultivadas, según la reivindicación 3, caracterizado por:4. Procedure for obtaining antibiotics, from the cultivated strains, according to claim 3, characterized by: - Extracción selectiva del caldo marino y los lisados de los cultivos de CF-20 y C-148. - Obtención del extracto activo por utilización de disolventes orgánicos de distintas polaridades.- Selective extraction of marine broth and lysates from CF-20 and C-148 cultures. - Obtaining the active extract by using organic solvents of different polarities. - Separación cromatográfϊca en silica gel del extracto activo que proporciona varias fracciones activas.- Chromatographic separation in silica gel of the active extract that provides several active fractions. - Aislamiento por HPLC en cantidades de mg de los componentes activos puros.- Isolation by HPLC in amounts of mg of the pure active components. 5- Procedimiento de obtención de los antibióticos a partir de la cepa CF-20, según la reivindicación 4, caracterizado porque los compuestos presentan estructura de dicetopiperazinas, correspondiendo a: Z54: ciclo(D)-prolina-(D)-Isoleucina; Z56: ciclo(D)-prolina-(D)-Leucina;5- Method of obtaining antibiotics from strain CF-20, according to claim 4, characterized in that the compounds have a diketopiperazine structure, corresponding to: Z54: cycle (D) -proline- (D) -Isoleucin; Z56: cycle (D) -proline- (D) -Leucine; Z57: ciclo(D)-prolina-(D)-valina; Z59: ciclo(D)-prolina-(D)-fenilalanina.Z57: cycle (D) -proline- (D) -valine; Z59: cycle (D) -proline- (D) -phenylalanine. 6.- Procedimiento de obtención de los antibióticos a partir de la cepa C-148, según la reivindicación 4, caracterizado porque los compuestos presentan, estructura de dicetopiperazinas, correspondiendo a: Z54: ciclo(D)-prolina-(D)-Isoleucina; Z56: ciclo(D)-prolina-(D)-Leucina;6. Method for obtaining antibiotics from strain C-148, according to claim 4, characterized in that the compounds have a diketopiperazine structure, corresponding to: Z54: cycle (D) -proline- (D) -Isoleucin ; Z56: cycle (D) -proline- (D) -Leucine; Z57: ciclo(D)-prolina-(D)-valina; Z59: ciclo(D)-prolina-(D)-fenilalanina; y B717: ciclo(D)- trans-4-hidroxiprolinil-(D)-fenilalanina.Z57: cycle (D) -proline- (D) -valine; Z59: cycle (D) -proline- (D) -phenylalanine; and B717: cycle (D) - trans-4-hydroxypropyl- (D) -phenylalanine. 7.- Nuevos antibióticos naturales, según las reivindicaciones 5 y 6, correspondientes a las dicetopiperazinas con estructura I: Z54, Z56, Z57, Z59 y B717 aislados de las bacterias marinas CF-20 y C-148. 7. New natural antibiotics, according to claims 5 and 6, corresponding to the diketopiperazines with structure I: Z54, Z56, Z57, Z59 and B717 isolated from marine bacteria CF-20 and C-148. 8.- Utilización en acuicultura de las dicetopiperacinas con estructura I, y estereoquímica absoluta D-D, D-L y L-D, derivadas de los D y L- α-aminoácidos naturales y sintéticos, y las dicetopiperacinas con estereoquímica absoluta D, derivadas de glicina, y cualquiera de los otros D- α-aminoácidos naturales o sintéticos, donde Ri y R2 pueden ser iguales o diferentes y corresponden a las cadenas laterales de los α-aminoácidos de origen natural o sintético, incluyendo 4-hidroxiprolina, hidroxilisina, demosina, isodemosina, 3-metilhistidina, norvalina, citrulina homocisteina, homocistina, homoserina, ornitina y metionina sulfono, cis y trans-α- (carboxiciclopropilo)glicina, α-(metilenociclopropilo)glicina, y los radicales R3 y R-ι, iguales o diferentes, pueden ser H, alquilo, alquenilo, alquinilo, alquilarilo, arilo, acilo, carboxialquilo, carboxialquenilo, carboxialquinilo, carboxiarilo, carboxialquilarilo, como antibióticos contra Vibrio anguillarum y flora bacteriana en cultivos de moluscos, crustáceos y peces.8.- Use in aquaculture of diketopiperacins with structure I, and absolute stereochemistry DD, DL and LD, derived from natural and synthetic D and L-α-amino acids, and diketopiperacins with absolute stereochemistry D, derived from glycine, and any of the other natural or synthetic D-α-amino acids, where Ri and R 2 may be the same or different and correspond to the side chains of the α-amino acids of natural or synthetic origin, including 4-hydroxyproline, hydroxylysine, demosin, isodemosin, 3-methylhistidine, norvaline, homocysteine citrulline, homocysteine, homoserine, ornithine and methionine sulfone, cis and trans-α- (carboxycyclopropyl) glycine, α- (methylenecyclopropyl) glycine, and the radicals R 3 and R-ι, the same or different, they can be H, alkyl, alkenyl, alkynyl, alkylaryl, aryl, acyl, carboxyalkyl, carboxyalkenyl, carboxyalkynyl, carboxyaryl, carboxyalkylaryl, as antibiotics against Vibrio anguillarum and bacterial flora in c Ultimate mollusks, crustaceans and fish.
Figure imgf000020_0001
I
Figure imgf000020_0001
I
9.- Utilización en acuicultura de los compuestos con estructura I, tales como Z54, Z56, Z57, Z59 y B717, como antibióticos contra Vibrio anguillarum y flora bacteriana en cultivos de moluscos, crustáceos y peces.9.- Use in aquaculture of compounds with structure I, such as Z54, Z56, Z57, Z59 and B717, as antibiotics against Vibrio anguillarum and bacterial flora in shellfish, crustacean and fish crops. 10.- Utilización de los antibióticos, según las reivindicaciones 1, 4-9, solos o en combinación con otros agentes, en la preparación, de cualquier clase de forma farmacéutica, de aditivos alimentarios, de productos con microalgas, de artemia, de rotíferos, de piensos para el tratamiento de las enfermedades en cultivo de peces, crustáceos y moluscos y actividades de acuicultura. 10. Use of antibiotics, according to claims 1, 4-9, alone or in combination with other agents, in the preparation, of any kind of pharmaceutical form, of food additives, of products with microalgae, of artemia, of rotifers of feed for the treatment of diseases in fish culture, crustaceans and molluscs and aquaculture activities.
PCT/ES2003/000325 2002-07-02 2003-07-01 Novel antibiotics against vibrio anguillarum and the applications thereof in cultures of fish, crustaceans, molluscs and other aquaculture activities Ceased WO2004005292A1 (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
ESP200201537 2002-07-02
ES200201537A ES2204294B2 (en) 2002-07-02 2002-07-02 NEW ACTIVE ANTIBIOTICS AGAINST THE ANGUILLARUM VIBRIO AND ITS APPLICATIONS IN CROPS OF FISH, CRUSTACEANS, MOLLUSCS AND OTHER AQUACULTURE ACTIVITIES.

Publications (1)

Publication Number Publication Date
WO2004005292A1 true WO2004005292A1 (en) 2004-01-15

Family

ID=30011349

Family Applications (1)

Application Number Title Priority Date Filing Date
PCT/ES2003/000325 Ceased WO2004005292A1 (en) 2002-07-02 2003-07-01 Novel antibiotics against vibrio anguillarum and the applications thereof in cultures of fish, crustaceans, molluscs and other aquaculture activities

Country Status (2)

Country Link
ES (1) ES2204294B2 (en)
WO (1) WO2004005292A1 (en)

Cited By (12)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US7706594B2 (en) 2004-06-18 2010-04-27 Xerox Corporation Magnetic watermark for text documents
US20100144611A1 (en) * 2003-05-15 2010-06-10 David Bar-Or Treatment of t-cell mediated diseases
CN103145716A (en) * 2013-01-30 2013-06-12 青岛农业大学 Technique for preparing and separating cyclic dipeptide C6 from phellinus igniarius bacteria in high pressure opposite-phase mode
US9522893B2 (en) 2008-05-27 2016-12-20 Ampio Pharmaceuticals, Inc. Therapeutic methods and compounds
US9561226B2 (en) 2000-08-04 2017-02-07 Ampio Pharmaceuticals, Inc. Method of using diketopiperazines and composition containing them
US9623072B2 (en) 2011-10-10 2017-04-18 Ampio Pharmaceuticals, Inc. Treatment of degenerative joint disease
US9808454B2 (en) 2013-03-15 2017-11-07 Ampio Pharmaceuticals, Inc. Compositions for the mobilization, homing, expansion and differentiation of stem cells and methods of using the same
US9925300B2 (en) 2011-10-10 2018-03-27 Ampio Pharmaceuticals, Inc. Implantable medical devices with increased immune tolerance, and methods for making and implanting
US9956217B2 (en) 2014-08-18 2018-05-01 Ampio Pharmaceuticals, Inc. Treatment of joint conditions
US10881710B2 (en) 2011-10-28 2021-01-05 Ampio Pharmaceuticals, Inc. Treatment of rhinitis
US11389512B2 (en) 2015-06-22 2022-07-19 Ampio Pharmaceuticals, Inc. Use of low molecular weight fractions of human serum albumin in treating diseases
CN116058433A (en) * 2023-02-28 2023-05-05 宁波大学 Application of seashore rose color-changing bacteria in promoting growth of portunus trituberculatus

Families Citing this family (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN111072670B (en) * 2019-12-19 2022-04-19 宁波大学 Diketopiperazine compound and preparation method and application thereof

Citations (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4006261A (en) * 1973-09-28 1977-02-01 Firmenich S.A. Flavoring with mixtures of theobromine and cyclic dipeptides

Patent Citations (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4006261A (en) * 1973-09-28 1977-02-01 Firmenich S.A. Flavoring with mixtures of theobromine and cyclic dipeptides

Non-Patent Citations (5)

* Cited by examiner, † Cited by third party
Title
DEBITUS C. ET AL.: "Quinolones from a bacterium and tyrosine metabolites from its host sponge, suberea creba from the coral sea", JOURNAL OF MARINE BIOTECHNOLOGY, vol. 6, 1998, pages 136 - 141 *
JAYATILAKE G.S. ET AL.: "Metabolites from an antarctic sponge - associated bacterium", J. NAT. PROD., vol. 59, 1996, pages 293 - 296, XP002300316, DOI: doi:10.1021/np960095b *
JIA X. ET AL.: "Antimicrobial peptides protect coho salmon from vibrio anguillarum infections", APPLIED AND ENVIRONMENTAL MICROBIOLOGY, vol. 66, no. 5, 2000, pages 1928 - 1932 *
JIANG Z. ET AL.: "Two diketopiperazines and one halogenated phenol from cultures of the marine bacterium, pseudoalteromonas luteoviolacea", NATURAL PRODUCT LETTERS, vol. 14, no. 6, 2000, pages 435 - 440 *
RUIZ PONTE C. ET AL.: "The benefit of roseobacter species on the survival of scallop larvae", MARINE BIOTECHNOLOGY, vol. 1, 1999, pages 52 - 59, XP003011875, DOI: doi:10.1007/PL00011751 *

Cited By (25)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US10039760B2 (en) 2000-08-04 2018-08-07 Ampio Pharmaceuticals, Inc. Method of using diketopiperazines and composition containing them
US9561226B2 (en) 2000-08-04 2017-02-07 Ampio Pharmaceuticals, Inc. Method of using diketopiperazines and composition containing them
US20100144611A1 (en) * 2003-05-15 2010-06-10 David Bar-Or Treatment of t-cell mediated diseases
US11369598B2 (en) 2003-05-15 2022-06-28 Ampio Pharmaceuticals, Inc. Treatment of T-cell mediated diseases
US10828296B2 (en) 2003-05-15 2020-11-10 Ampio Pharmaceuticals, Inc. Treatment of T-cell mediated diseases
US9707227B2 (en) * 2003-05-15 2017-07-18 Ampio Pharmaceuticals, Inc. Treatment of T-cell mediated diseases
US9730924B2 (en) 2003-05-15 2017-08-15 Ampio Pharmaceuticals, Inc. Treatment of T-cell mediated diseases
US7706594B2 (en) 2004-06-18 2010-04-27 Xerox Corporation Magnetic watermark for text documents
US9522893B2 (en) 2008-05-27 2016-12-20 Ampio Pharmaceuticals, Inc. Therapeutic methods and compounds
US9623072B2 (en) 2011-10-10 2017-04-18 Ampio Pharmaceuticals, Inc. Treatment of degenerative joint disease
US9925300B2 (en) 2011-10-10 2018-03-27 Ampio Pharmaceuticals, Inc. Implantable medical devices with increased immune tolerance, and methods for making and implanting
US11058798B2 (en) 2011-10-10 2021-07-13 Ampio Pharmaceuticals, Inc. Implantable medical devices with increased immune tolerance, and methods for making and implanting
US10251930B2 (en) 2011-10-10 2019-04-09 Ampio Pharmaceuticals, Inc. Treatment of degenerative joint disease
US10842847B2 (en) 2011-10-10 2020-11-24 Ampio Pharmaceuticals, Inc. Treatment of degenerative joint disease
US10471178B2 (en) 2011-10-10 2019-11-12 Ampio Pharmaceuticals, Inc. Implantable medical devices with increased immune tolerance, and methods for making and implanting
US10881710B2 (en) 2011-10-28 2021-01-05 Ampio Pharmaceuticals, Inc. Treatment of rhinitis
CN103145716B (en) * 2013-01-30 2016-03-30 青岛农业大学 The anti-phase preparative separation technology of the high pressure of Cyclic dipeptides C6 in Phellinus bacterium
CN103145716A (en) * 2013-01-30 2013-06-12 青岛农业大学 Technique for preparing and separating cyclic dipeptide C6 from phellinus igniarius bacteria in high pressure opposite-phase mode
US9808454B2 (en) 2013-03-15 2017-11-07 Ampio Pharmaceuticals, Inc. Compositions for the mobilization, homing, expansion and differentiation of stem cells and methods of using the same
US11026940B2 (en) 2013-03-15 2021-06-08 Ampio Pharmaceuticals, Inc. Compositions for the mobilization, homing, expansion and differentiation of stem cells and methods of using the same
US10342793B2 (en) 2014-08-18 2019-07-09 Ampio Pharmaceuticals, Inc. Treatment of joint conditions
US9956217B2 (en) 2014-08-18 2018-05-01 Ampio Pharmaceuticals, Inc. Treatment of joint conditions
US11090301B2 (en) 2014-08-18 2021-08-17 Ampio Pharmaceuticals, Inc. Treatment of joint conditions
US11389512B2 (en) 2015-06-22 2022-07-19 Ampio Pharmaceuticals, Inc. Use of low molecular weight fractions of human serum albumin in treating diseases
CN116058433A (en) * 2023-02-28 2023-05-05 宁波大学 Application of seashore rose color-changing bacteria in promoting growth of portunus trituberculatus

Also Published As

Publication number Publication date
ES2204294B2 (en) 2005-02-01
ES2204294A1 (en) 2004-04-16

Similar Documents

Publication Publication Date Title
Daloze et al. Ladybird defence alkaloids: structural, chemotaxonomic and biosynthetic aspects (Col.: Coccinellidae)
Yasumoto et al. Marine toxins
ES2204294B2 (en) NEW ACTIVE ANTIBIOTICS AGAINST THE ANGUILLARUM VIBRIO AND ITS APPLICATIONS IN CROPS OF FISH, CRUSTACEANS, MOLLUSCS AND OTHER AQUACULTURE ACTIVITIES.
Wakabayashi et al. Characteristics of myxobacteria associated with some freshwater fish diseases in Japan
BRPI1016243B1 (en) Mollusk Control Methods
Kumar et al. Purification, structural elucidation and bioactivity of tryptophan containing diketopiperazines, from Comamonas testosteroni associated with a rhabditid entomopathogenic nematode against major human-pathogenic bacteria
MXPA97002124A (en) Novedous sphingolipids and its procedimie
Ireland et al. Natural product peptides from marine organisms
JPH06501849A (en) Non-toxic microorganisms and their uses: Salmonella typhi
CN105473704B (en) Application, cyclic lipopeptide and its application of separation of bacterial from Pseudoalteromonas
Davis et al. Bioorganic marine chemistry
Wards et al. Characterisation by restriction endonuclease analysis and plasmid profiling of Vibrio ordalii strains from salmon (Oncorhynchus tshawytscha and Oncorhynchus nerka) with vibriosis in New Zealand
US8841341B2 (en) Pharmaceutical composition effective against biofilms
CN112961170B (en) A spongy-derived actinomycete and the preparation method and application of the produced sulfur-containing alkaloids
EP1369426B1 (en) Peptides, derivatives thereof, process for producing the same, strain producing the same, and antiviral agent comprising the same as active ingredient
ES2304954T3 (en) PSEUDOMYCIN ANALOGS
US4874767A (en) Discorhabdin D, compositions containing same and methods of preparatio and use thereof
Dao Chemical investigation of candidate probiotics in aquaculture and formulation of a probiotic agent for oyster larviculure
JP2012240974A (en) Method for producing didemnin b
KR100225458B1 (en) Myxococcus spantitumor compound from myxococcus sp. and process for preparation thereof
Ranson Chemical Investigation of Bacterial Interactions Involving Pathogens
Grant Ranson CHEMICAL INVESTIGATION OF BACTERIAL INTERACTIONS INVOLVING PATHOGENS
CA2172854C (en) Antimicrobial indole derivatives
ES2459941T3 (en) Preparation and use of antitumor cyclodepsypeptides, antibiotics and insecticides
Gerard Antibiotic secondary metabolities of bacteria isolated from the marine environment

Legal Events

Date Code Title Description
AK Designated states

Kind code of ref document: A1

Designated state(s): CA US

AL Designated countries for regional patents

Kind code of ref document: A1

Designated state(s): AT BE BG CH CY CZ DE DK EE ES FI FR GB GR HU IE IT LU MC NL PT SE SI SK TR

121 Ep: the epo has been informed by wipo that ep was designated in this application
122 Ep: pct application non-entry in european phase